For Companies

Senior finance leadership for
health care innovators

A thought partner to founders, CEOs, and boards navigating strategic finance decisions, capital raises, and the finance function itself.

"Big firms sell what they've already built. A boutique advisor builds what the company needs."

Green Shoots engagements are custom-built to the company, the stage, the team, and the moment. A pre-revenue diagnostics company preparing for its first institutional round has different needs than a growth-stage medical device company navigating commercial launch. A founder-led biotech with two people in finance requires a different working style than a Series C health tech company with an established Controller. Green Shoots adapts — nimble, senior, and shaped to what each company actually needs, when it needs it.

Strategic Finance Advisory

Green Shoots partners with founders, CEOs, and boards on the highest-stakes financial decisions a growth-stage company faces — evaluating commercial strategy options, sizing addressable markets, building the analytical foundation for major pivots, and framing choices for board and investor discussions. Engagements often involve commissioning primary market research through specialist firms to inform the analysis, then translating that research into decision-ready models and board materials that connect market opportunity to financial outcomes.

Capital Raise Support

Green Shoots supports growth-stage companies through the full arc of a capital raise — from investor sourcing and warm introductions across a deep venture capital network, to preparation of investor materials, financial models, and management presentations, to term sheet negotiation and closing. Green Shoots has sourced key investors and closed rounds ranging from convertible notes to Series C financings, and brings both the strategic perspective of a former venture investor and the operational discipline of a fractional CFO to every process.

Fractional CFO Leadership

Green Shoots serves as fractional CFO for growth-stage health care companies that need partner-level finance leadership without the cost or commitment of a full-time hire. Engagements have ranged from interim leadership during CFO transitions to ongoing finance partnership through commercial launch, capital raises, and strategic transactions. The focus is on the strategic side of the CFO role — FP&A leadership, board and investor reporting, launch forecasting, capital raise support, and helping founders and CEOs navigate the financial decisions that shape the trajectory of the business.

Select Engagements

Case Study #1

Commercial Strategy — Digital Radiomics Platform
Weighted Scorecard — Strategic Trade-offs DTC WELLNESS FDA DX REIMBURSED CRO SERVICES Total Addressable Market Margin Profile Operational Demands Capital Requirement Time to Break-Even Risk Overall Attractiveness ILLUSTRATIVE FRAMEWORK ONLY

A growth-stage health tech company with a digital radiomics platform engaged Green Shoots as fractional CFO during a pivotal period. The board and management team were weighing three fundamentally different commercial strategies: a direct-to-consumer wellness offering, a fully FDA-approved and insurance-reimbursed diagnostic, or a CRO-style clinical services model for pharmaceutical clients.

Green Shoots commissioned an external market research firm to conduct market sizing across all three paths, then built addressable market, revenue, and DCF models to translate the research into financial projections. The analysis was structured to make the strategic trade-offs visible — operational demands, capital intensity, gross margin profile, time to break-even, and risk-adjusted returns for each commercial path. The end result was a well-researched frame of reference for the board and management to understand the options and align on a path forward.

Case Study #2

Commercial Launch & Financing — Medical Device Company
Commercial Model — Key Assumptions H1 '26 H2 '26 H1 '27 H2 '27 H1 '28 Units Sold 1,920 3,840 6,720 10,880 15,360 List Price ($) 4,500 4,500 4,650 4,650 4,800 Avg Discount 15% 18% 17% 16% 15% % Medicare / Medicaid 30% 32% 35% 38% 40% % Commercial 55% 54% 52% 50% 48% % DTC 15% 14% 13% 12% 12% % Refunds & Returns 3.0% 2.5% 2.2% 2.0% 2.0% Net Revenue ($K) 7,124 13,815 25,365 41,647 61,415 % Commission Rate 12% 12% 11% 10% 10% % Warranty Accrual 3.5% 3.0% 2.8% 2.5% 2.5% % Bad Debt Reserve 2.0% 1.8% 1.5% 1.5% 1.5% ILLUSTRATIVE FRAMEWORK ONLY

A medical device company preparing for its U.S. commercial launch engaged Green Shoots as fractional CFO with two simultaneous mandates: help the CEO and Chief Commercial Officer develop a go-to-market plan, and raise sufficient capital to fund the launch.

On the commercial side, Green Shoots facilitated working sessions with the CEO, Chief Commercial Officer, Chief Operating Officer, and Finance Director to pressure-test the go-to-market strategy across every key launch decision — pricing, discount and financing structures, product bundling, market channels, distributor relationships, warranties, bad debt, and commission structures. A detailed revenue model was built to document the resulting thinking and serve as the working analytical framework, evolving through significant iteration as commercial strategy took shape.

In parallel, Green Shoots built a higher-level revenue build and accompanying three-statement financial model for fundraising purposes, translating the commercial strategy into a coherent story for prospective investors. Green Shoots reviewed the models and discussed them directly with all key investors in the process.

Green Shoots also sourced the investor who ultimately committed the largest check in the round — enabling the financing to reach its size threshold and close successfully. The introduction was made through Green Shoots' existing venture capital network, built over two decades of investing and advisory relationships in the sector.

Green Shoots Consulting, LLC provides analytical and strategic advisory services. Content on this site is for informational purposes only and does not constitute investment advice, a formal valuation opinion, or an offer to buy or sell any security. Green Shoots Consulting, LLC is not a registered investment adviser or broker-dealer. Full disclaimer →